The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
In parallel with the 510K application, TruSpine has commissioned Emergo, to prepare and file a submission requesting that the FDA examine the Cervi-LOK™ to be designated as a "Breakthrough Device". This requires a new Q-Sub application which will require additional time to prepare but will confer significant long-term benefits on the Cervi-LOK™ and its commercialisation. This can include higher margin returns through preferred insurance coding and hospital reimbursement.
Breakthrough device sounds really good.
Amazing progress overall. Lots have been done. Oberon active as a broker is very good news as well.
Raise 20% ABOVE the current SP, with Warrants almost 80% ABOVE the current SP. This instils confidence in investors and will provide lots more cash to the company once the SP hits above 15p per share
The following have now been completed since the last update to market in April 2021:
· Testing and design freeze of Cervi-LOK™ product
· Testing and design freeze of Cervi-LOK™ instrumentation
· Completion of three Cadaver Studies
· Appointment of Anthony Swoboda as US Vice President of sales and marketing,
· Appointment of consultant neurosurgeon Nik Patel as a Non-Executive Director
· Appointment of William Lavalle, M.D., as the Chairman of our Medical Advisory board
Just research the company buddy.
In short:
£20m MCAP company with 670k oz JORC (So around $1.3B based on the current $1800 price per oz) compliant resources and PRODUCING at the Kilimapesa mine at the rate of 500oz/month
5.5M cash in the bank.
Plans to increase production to 1500oz/month and to obtain further projects towards 2m oz
Mine itself underwent $20M worth of maintenance.
You can see why its undervalued, its assets and money spent are way more than the entire mcap.
Not a ramp, stating pure facts here
Likewise, payinattn, the SP shouldn't have tanked by 80% as a result of delays due to Covid. It works both ways.
SP is going up because smart investors are accumulating before the inevitable happens. There is a reason why Oberon is now 5.81% (who have increased their stake by another 1% very recently) and Annabel Schild holds 4.75%
49% of overall shares are not in public hands.
Just stating the facts.
Finn was on fire. Amazing explanation of the tech, learned a lot more. It was nice to hear from the different voice as well.
I could clearly feel the energy coming from all presenters, they do sound genuine and passionate over what they do.
Good projection over what is happening in not so distant future.
Oh, thanks for the update regarding the launch of an Android STC end of next month!
https://uk.advfn.com/stock-market/london/helium-one-global-HE1/share-news/Helium-One-Global-Ltd-Holdings-in-Company/85634874
They have also got almost 3% of Helium One
https://investegate.co.uk/truspine-technolgs.--tsp-/rns/holding-s--in-company/202107231132013067G/
Looks like Oberon keeps accumulating positions in good companies.
Muggings, thats incorrect, there was a lot in between.
Anyone reading his post, please bear in mind that it was 75p to 20p last year, due to the Helium selling.
SP then rose to around 40p and have been pretty stable between 30p and 35p.
Markets are down this week, everywhere. Most of my PF is red this week and it seems to be a common theme in AIM this week. Just one of these period where market is battered.
I regularly come across 50-100 mil valuations on the companies that have an idea and nothing else
Truspine is undervalued at less than 10 million.
It is not the company with an idea, it already has a developed product that has done testing. The concept was proven. Technology is patented and revolutionary as well as disruptive.
It is far from just the company with just an idea.
Bitcoin and meme traders are complaining about 50% revenue increase ) no wonder why people lose money in the stock market as expectations are so out of touch with the real world.
SP is completely detached from the progress company is making. One is not necessarily follow the other.
Many good businesses have their SP going down during Covid announcement, even when their profits and business strategy haven't changed! That's when you shop for bargains.
Just review the fundamentals. Yes, the company is still in debt, however it is reducing and profits are getting higher. Growth and expansion is there.
Also, think of other assets here. Dvrg has the largest microbiome database in the world. How much is that data is worth? It is not even valued!
Two Level 3 labs, how many private companies have that in their possession? Can you put a price tag on this?
What about other Intellectual property?
Deepverges assets in my view, are worth more than the current mcap, now combine that with YOY revenue increases.
If upon your review you will find out that the company is overvalued, then I would suggest to sell and find something else.
Ignore the noise, even ignore GBs exciting tweets. You can just stick to RNS' to figure out whether the company is making the progress.
Damn, seems like bitcoin traders have hijacked this forum, expecting gazilions within 5 minutes of investing and all reports and RNS' on the dot at 7am. Pathetic people
Yep, someone parted with £500k
Not a small amount...combined with the recent £10mil institutional investment at 30p as well as Ross Andrews buying 150k shares at 33.72 pence just 2 months ago.
For me, this is a textbook moment from "One up on Wall Street" by Peter Lynch.
https://www.investegate.co.uk/truspine-technolgs.--tsp-/rns/appointment-of-vice-president-of-sales---marketing/202106230700057666C/
Not sure if anyone has seen this already?
An absolutely amazing appointment of the new VP of TruSpine.
Mr Swoboda is a very experienced person in the field and have previously worked for Medtronic for 8 years.
No doubt he will be the driving force of expanding TruSpines products across US.
Ducks are getting into the row now!